FDA has Named a New Director for its Office of Women's Health

Kathleen Uhl, M.D., FAAFP, has been appointed as the new director of the FDA's Office of Women's Health. The previous director, Dr. Susan Wood, resigned in August in response to the FDA's handling of the Plan B decision. An interview with Wood appears in the current Nerve magazine.

According to the FDA's press release, Uhl is board certified in Family Medicine, first joined the FDA in 1998, most recently as Supervisory Medical Officer in CDER's Pregnancy and Lactation Labeling Team in the Office of New Drugs, and will take on the role in mid-December.
Technorati Tags: FDA
MeSH Tags: United States Food and Drug Administration